Close Navigation
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
Overlay

Investor Relations

Public market access to revolutionary medical innovation

Overview Investment Case News Results Documents Events Calendar Analysts Stock info Contact Transaction
Investor Relations Navigation

Welcome to the Investor Centre

Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

Our main goals are to make a difference to patients' lives and generate a superior return for our investors.

Latest Presentation

April 25th 2023

Interim Results for Six Months Ended 30 June 2023

Media

Read the latest media coverage on Arix here

Document Library

Find AGM, Corporate Governance and regulatory materials here

Regulatory News

Stay up to date with company news

Results Centre

View our latest numbers and financial reports here

Stock Info

Interactive share price chart of Arix on LSE

Financial Calendar

Key financial dates to add to your diary, including results and AGM

Analysts & Advisers

Find contact details for our analysts and advisers here

Shareholder Information

Key contacts and FAQs

Latest Annual Report
Download

Annual Report and Accounts

For the year ended 31st Dec 2022

INTERIM RESULTS

for the six months ended 30 June 2023

Interim ReportAsk a question

Highlights

£239m

NAV (at 30 June 2023)

185p

NAV per share (at 30 June 2023)

£101m

Cash (at 30 June 2023)

£134.4m

GPV (at 30 June 2023)

LON:ARIX